|
Volumn 36, Issue 1, 2008, Pages
|
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
a a a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
BLOCKING ANTIBODY;
IMMUNOLOGICAL ADJUVANT;
INTERFERON BETA SERINE;
INTERFERON BETA-1B;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
HUMAN;
IMMUNOLOGY;
MULTIPLE SCLEROSIS;
NOTE;
SERODIAGNOSIS;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, BLOCKING;
CLINICAL TRIALS AS TOPIC;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
NEUTRALIZATION TESTS;
TREATMENT OUTCOME;
|
EID: 41949135130
PISSN: 03000605
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (3)
|
References (0)
|